Trivalent Ganglioside Vaccine With Immunological Adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trivalent Ganglioside Vaccine With Immunological Adjuvant, covering 2016-12-07 to 2016-12-07. Get the full timeline:
Most recent: Clinical Trial Update: Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free [Phase 2]